Categories List
Payment Methods
Shipping Option
Shopping cart
People who bought this, also bought:
Microzide is a diuretic used to lower blood pressure and prevent heart attacks, strokes, and kidney problems.
$0.50
Buy now
Norvasc is a calcium channel blocker prescribed to treat hypertension, ischemic heart disease, angina.
$0.45
Buy now
Aldactone is a diuretic (water pill) indicated to treat hypertension, fluid retention associated with congestive heart failure, cirrhosis, and nephrotic syndrome.
$0.38
Buy now
Inderal is a beta-adrenergic receptor blocker and is used to treat angina, hypertension and heart rhythm disorders.
$0.40
Buy now
Aceon an angiotensin-converting enzyme inhibitor is used to control hypertension and to prevent heart attack in patients with coronary artery disease
$1.06
Buy now
Wellbutrin SR is an antidepressant from aminoketone class prescribed to relieve major depression.
$0.99
Buy now
Plavix prevents formation of blood clots and is prescribed to reduce the risk of circulation problems, stroke and heart attack.
$0.62
Buy now
Testimonials
Eric Anderson
First skeptical about this site which I've never bought from I called their customer support and learned all details of placing an order and delivery process. The price was reasonable so I decided to give ... Peter Hans
I am satisfied with quality of products and service. On line chat was helpful when I had questions. My order arrived in a matter of days exactly the same as I saw at the site. No blames. 
Social bookmarks
News
Jeremy Clarkson in remission from prostate cancer
The presenter shared his "aggressive" cancer diagnosis on an episode of Clarkson's Farm earlier this week. Minimum age of 11 set for UK puberty blocker trial
Gender-questioning children will have to be at least 11 years old to take part in a clinical trial of puberty-blocking drugs. Five tips to keep your kids cool this weekend
Temperatures are set to rise over the next few days, and children can be especially vulnerable - so read on for tips to protect them. Young women now have 'close to zero' risk of cervical cancer death after HPV jab
A new study finds that hundreds of lives have been saved since school-age girls were offered the HPV jab in 2008.